Lisata Therapeutics Inc (LSTA) Stock Price, Quote & News

Company Profile

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimen...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 842 0100

Website: www.lisata.com

Address:

110 Allen Road, 2nd Floor, Basking Ridge, United States

PyraWeb Jul. 31 at 8:56 PM

$LSTA time for this company to stop being such a little b!tch. Mazzo get up and find some buyers ffs…they should also lose some dead weight at the company. I dunno, it isn’t working as it is…stock price says it all. Time to finally execute on the science, been waiting. Needs to break back over 2.66, else it likely goes to the 1s…I think it will via inverse HS. We don’t have a firm R shoulder yet, but it can dip down to 2.30 and a bit more and still be that.

0 · Reply

TwongStocks Jul. 25 at 12:16 PM

$LSTA Confirmed that they will present updated results from the ASCEND trial, including pooled placebo analysis, at the upcoming ESMO Annual Congress in October. https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal_2/presentation/list?q=Ascend&r=pt%7E13 ESMO Congress is October 17-21. The abstract will be online at 00:05 CEST on Oct 13 (6:05pm EDT Oct 12). This is likely the pooled Cohort A and B data.

3 · Reply

cocoover1 Jul. 25 at 10:38 AM

$LSTA garbage.

0 · Reply

username15663 Jul. 23 at 10:13 PM

$LSTA looking to start a position. Any specific DD I should look into?

0 · Reply

ConstanceAtkeson887 Jul. 23 at 4:35 PM

$LSTA investors like strategic partnerships. RMTG just partnered with top Puerto Rican physicians to anchor a new regenerative clinic hub.

0 · Reply

PyraWeb Jul. 22 at 1:41 PM

$LSTA nothing to see here, just someone desperately trying to prevent the golden MA cross.

0 · Reply

EdwardTeach Jul. 22 at 1:17 PM

$LSTA hang in there, it's going to get better...glta

0 · Reply

KP2021 Jul. 22 at 12:49 PM

$LSTA

0 · Reply

KP2021 Jul. 22 at 12:47 PM

$LSTA

0 · Reply

KP2021 Jul. 22 at 9:50 AM

$AZN.L & $LSTA

2 · Reply

Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025

Jul 17, 2025, 8:00 AM EDT - 16 days ago

Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update

Jul 15, 2025, 8:00 AM EDT - 18 days ago

Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide

Jun 17, 2025, 8:00 AM EDT - 6 weeks ago

Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development

Jun 11, 2025, 8:30 AM EDT - 7 weeks ago

Lisata Therapeutics to Present at the 2025 BIO International Convention

May 8, 2025, 9:57 PM EDT - 3 months ago

Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 4:05 PM EDT - 3 months ago

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 1, 2025, 8:00 AM EDT - 3 months ago

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

Apr 15, 2025, 8:00 AM EDT - 3 months ago

Lisata Therapeutics Announces Research License with Catalent

Mar 6, 2025, 8:30 AM EST - 5 months ago

Lisata Therapeutics to Present at the Investival Showcase USA

Mar 5, 2025, 8:30 AM EST - 5 months ago

Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development

Feb 27, 2025, 10:06 PM EST - 5 months ago

Lisata Therapeutics, Inc. (LSTA) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 5 months ago

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Feb 20, 2025, 8:00 AM EST - 5 months ago

Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025

Jan 15, 2025, 8:30 AM EST - 7 months ago

Lisata Therapeutics to Present at the 2025 Sequire Investor Summit

Dec 10, 2024, 8:30 AM EST - 8 months ago

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

Nov 19, 2024, 8:30 AM EST - 9 months ago

Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year'

Nov 12, 2024, 10:07 PM EST - 9 months ago

Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 9 months ago

Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 9:23 AM EST - 9 months ago

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

Nov 6, 2024, 8:30 AM EST - 9 months ago

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

Oct 31, 2024, 8:30 AM EDT - 9 months ago

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

Oct 28, 2024, 8:30 AM EDT - 9 months ago

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis

Sep 9, 2024, 8:00 AM EDT - 11 months ago

Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events

Sep 5, 2024, 8:00 AM EDT - 11 months ago

Lisata Therapeutics' Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma

Aug 13, 2024, 12:20 AM EDT - 1 year ago

Lisata Therapeutics, Inc. (LSTA) Q2 2024 Earnings Call Transcript

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Lisata Therapeutics' Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model

Jun 13, 2024, 8:30 AM EDT - 1 year ago

Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

May 28, 2024, 8:30 AM EDT - 1 year ago

Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events

May 20, 2024, 8:30 AM EDT - 1 year ago

Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer

May 9, 2024, 9:42 PM EDT - 1 year ago

Lisata Therapeutics, Inc. (LSTA) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 1 year ago

Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 2, 2024, 8:00 AM EDT - 1 year ago

Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024

Apr 23, 2024, 7:30 AM EDT - 1 year ago

Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu's Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Apr 9, 2024, 8:30 AM EDT - 1 year ago

Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma

Apr 3, 2024, 8:30 AM EDT - 1 year ago

Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events

Mar 21, 2024, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma

Feb 29, 2024, 8:41 PM EST - 1 year ago

Lisata Therapeutics, Inc. (LSTA) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Feb 22, 2024, 8:00 AM EST - 1 year ago

Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time

Feb 20, 2024, 8:00 AM EST - 1 year ago

Lisata Therapeutics to Present at BIO CEO & Investor Conference

Jan 18, 2024, 8:30 AM EST - 1 year ago

Lisata Therapeutics to Present at the Sequire Investor Summit in Puerto Rico

Jan 4, 2024, 8:00 AM EST - 1 year ago

Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy

Nov 28, 2023, 4:05 PM EST - 1 year ago

Lisata Therapeutics to Present at NobleCon19 Investor Conference

Nov 4, 2023, 10:27 AM EDT - 1 year ago

Lisata Therapeutics, Inc. (LSTA) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Lisata Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 2nd at 4:30 p.m. Eastern Time

Oct 24, 2023, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces First Patient Treated in the Cholangiocarcinoma Cohort of the BOLSTER Trial of LSTA1, a Novel Tumor-Targeting and Penetrating Peptide

Oct 17, 2023, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces European Medicines Agency Has Granted LSTA1 Orphan Drug Designation for the Treatment of Pancreatic Cancer

PyraWeb Jul. 31 at 8:56 PM

0 · Reply

TwongStocks Jul. 25 at 12:16 PM

3 · Reply

cocoover1 Jul. 25 at 10:38 AM

$LSTA garbage.

0 · Reply

username15663 Jul. 23 at 10:13 PM

$LSTA looking to start a position. Any specific DD I should look into?

0 · Reply

ConstanceAtkeson887 Jul. 23 at 4:35 PM

$LSTA investors like strategic partnerships. RMTG just partnered with top Puerto Rican physicians to anchor a new regenerative clinic hub.

0 · Reply

PyraWeb Jul. 22 at 1:41 PM

$LSTA nothing to see here, just someone desperately trying to prevent the golden MA cross.

0 · Reply

EdwardTeach Jul. 22 at 1:17 PM

$LSTA hang in there, it's going to get better...glta

0 · Reply

KP2021 Jul. 22 at 12:49 PM

$LSTA

0 · Reply

KP2021 Jul. 22 at 12:47 PM

$LSTA

0 · Reply

KP2021 Jul. 22 at 9:50 AM

$AZN.L & $LSTA

2 · Reply

TimRegan_WTR Jul. 21 at 10:50 PM

$LSTA

0 · Reply

JMAR_WTR Jul. 21 at 7:43 PM

$LSTA

0 · Reply

research_WTR Jul. 21 at 7:40 PM

Check out Robert Sassoon's recap following his latest podcast with Lisata Therapeutics, Inc. (NASDAQ:LSTA) CEO David J. Mazzo, Ph.D., PhD and Chief Medical Officer and Head of R&D Kristen K. Buck MD to talk about, Certepetide, the company’s novel solid tumor targeting and penetration technology with tumor microenvironment modifying properties. Those interested can listen to this podcast on Apple Podcasts, Spotify, or on our website. Links are accessible in our full report! https://www.watertowerresearch.com/doc?docID=IR_Healt_07172025 $LSTA #Lisata #Certepetide #Healthcare #Podcast #SmallCap #Stocks #Investing #WTRInsights

0 · Reply

TimRegan_WTR Jul. 18 at 3:38 PM

$LSTA

0 · Reply

JMAR_WTR Jul. 18 at 2:22 PM

$LSTA

0 · Reply

research_WTR Jul. 18 at 2:19 PM

On the latest WTR Healthcare Spotlight podcast, Tim Gerdeman and @robert_sassoon were joined by @lisata_tx (NASDAQ: LSTA) CEO David J. Mazzo, Ph.D., PhD, and CMO Kristen K. Buck MD, to discuss Certepetide—Lisata’s novel tumor-penetrating therapy—and encouraging preliminary Phase 2b results in metastatic pancreatic cancer. Tune in for insights on their lead program, key partnerships, and what’s next! Apple: https://podcasts.apple.com/us/podcast/lisata-therapeutics-ceo-dr-david-mazzo-and-cmo-dr/id1795488592?i=1000717947908 Spotify: https://open.spotify.com/episode/1tMC216pC6ygK6rN3xu0r0?si=b72443e8551a428d Website: https://www.watertowerresearch.com/media-detail/2231/Media All Platforms: https://pod.link/1693448305 $LSTA #Biotech #HealthcareStocks #CancerResearch #PancreaticCancer #LisataTherapeutics #ClinicalTrials #SmallCap #Stocks #Investing #InvestorInsights #WaterTowerResearch

0 · Reply

EdwardTeach Jul. 18 at 12:58 PM

I hope $LSTA doesn't come up with any more positive news...it might drop to the gray sheets...glta

1 · Reply

PyraWeb Jul. 17 at 8:26 PM

$LSTA price falls under the Thales line that has been a channel low for last three months. I want to see it reclaimed tomorrow, or it’s gonna get stupid again.

0 · Reply

cocoover1 Jul. 17 at 8:03 PM

$LSTA this thing is doing the opposite to what should it do. Lol

0 · Reply

EdwardTeach Jul. 17 at 1:47 PM

$LSTA why does the news show on think or swim but not the Charles Shwab app?

0 · Reply

EdwardTeach Jul. 17 at 1:09 PM

$LSTA this should have been going up all week. What's holding it back?

2 · Reply

EdwardTeach Jul. 17 at 12:22 PM

$LSTA https://www.stocktitan.net/news/LSTA/lisata-therapeutics-and-warpnine-announce-i-lsta-trial-enrollment-7nhvc7oo1k1a.html

0 · Reply

Market Cap	21.37M
Revenue (ttm)	1.00M
Net Income (ttm)	-19.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,999.00%
Debt to Equity Ratio	0.00

Volume	2,400
Avg Vol	30,420
Day's Range	N/A - N/A
Shares Out	8.62M
Stochastic %K	11%
Beta	1.03
Analysts	Strong Sell
Price Target	$23.50